Zonisamide (Zonegran) for epilepsy.
D000328:Adult; D000927:Anticonvulsants / Q000627:therapeutic use*; D001259:Ataxia / Q000139:chemically induced; D001682:Biological Availability; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004827:Epilepsy / Q000188:drug therapy*; D006207:Half-Life; D006801:Humans; D007555:Isoxazoles / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000078305:Zonisamide
D000927:Anticonvulsants; D002121:Calcium Channel Blockers; D007555:Isoxazoles; D000078305:Zonisamide